Elisa Espinet

3.7k total citations · 2 hit papers
18 papers, 2.1k citations indexed

About

Elisa Espinet is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Elisa Espinet has authored 18 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 4 papers in Immunology. Recurrent topics in Elisa Espinet's work include Pancreatic and Hepatic Oncology Research (7 papers), Epigenetics and DNA Methylation (3 papers) and Cancer Cells and Metastasis (3 papers). Elisa Espinet is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Epigenetics and DNA Methylation (3 papers) and Cancer Cells and Metastasis (3 papers). Elisa Espinet collaborates with scholars based in Germany, Spain and United States. Elisa Espinet's co-authors include Daniel Byrom, Mar Iglesias, Marta Sevillano, Alexandre Calon, Antoni Riéra, Eduard Batlle, David Rossell, Elena Sancho, Daniele V. F. Tauriello and Sergio Palomo‐Ponce and has published in prestigious journals such as Nature Communications, Nature Genetics and The EMBO Journal.

In The Last Decade

Elisa Espinet

18 papers receiving 2.0k citations

Hit Papers

Dependency of Colorectal Cancer on a TGF-β-Driven Program... 2012 2026 2016 2021 2012 2015 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Espinet Germany 12 1.3k 947 595 383 296 18 2.1k
Claudio Isella Italy 24 1.1k 0.9× 1.2k 1.3× 915 1.5× 240 0.6× 416 1.4× 50 2.3k
Therese M. Becker Australia 31 1.3k 1.0× 1.5k 1.6× 752 1.3× 274 0.7× 228 0.8× 89 2.6k
Ingrid Hedenfalk Sweden 28 824 0.6× 1.1k 1.1× 852 1.4× 387 1.0× 181 0.6× 78 2.4k
Michael Lahn United States 23 1.1k 0.9× 1.3k 1.4× 400 0.7× 369 1.0× 220 0.7× 42 2.2k
Daniel Byrom Spain 4 2.1k 1.6× 1.1k 1.2× 711 1.2× 838 2.2× 409 1.4× 5 3.0k
April A. N. Rose Canada 21 998 0.8× 958 1.0× 307 0.5× 336 0.9× 226 0.8× 57 1.9k
Kwan Ho Tang Hong Kong 14 1.3k 1.0× 1.5k 1.6× 870 1.5× 387 1.0× 129 0.4× 20 2.4k
Mari Iida United States 30 1.3k 1.0× 1.5k 1.6× 429 0.7× 456 1.2× 204 0.7× 62 2.8k
Rebeca Sanz‐Pamplona Spain 25 669 0.5× 885 0.9× 496 0.8× 252 0.7× 266 0.9× 67 1.8k
Jaana Lahti‐Domenici United States 13 1.1k 0.9× 1.3k 1.3× 750 1.3× 269 0.7× 260 0.9× 13 2.3k

Countries citing papers authored by Elisa Espinet

Since Specialization
Citations

This map shows the geographic impact of Elisa Espinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Espinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Espinet more than expected).

Fields of papers citing papers by Elisa Espinet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Espinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Espinet. The network helps show where Elisa Espinet may publish in the future.

Co-authorship network of co-authors of Elisa Espinet

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Espinet. A scholar is included among the top collaborators of Elisa Espinet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Espinet. Elisa Espinet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Steimbach, Raphael R., Marcin Luzarowski, Sibylle Schleich, et al.. (2025). Site-specific activation of the proton pump inhibitor rabeprazole by tetrathiolate zinc centres. Nature Chemistry. 17(4). 507–517. 1 indexed citations
2.
Janssen, Pauline, Marco Mambretti, Gamze Ates, et al.. (2024). Compartmentalized role of xCT in supporting pancreatic tumor growth, inflammation and mood disturbance in mice. Brain Behavior and Immunity. 118. 275–286. 2 indexed citations
3.
Rigotti, Francesca, Elisa Donato, Elisa Espinet, et al.. (2023). HAPLN1 potentiates peritoneal metastasis in pancreatic cancer. Nature Communications. 14(1). 2353–2353. 24 indexed citations
4.
Espinet, Elisa, et al.. (2023). A novel empeROR of pancreatic malignancy. The EMBO Journal. 42(14). e114282–e114282. 1 indexed citations
5.
Espinet, Elisa, Lukas Klein, Ellen Puré, & Shiv K. Singh. (2022). Mechanisms of PDAC subtype heterogeneity and therapy response. Trends in cancer. 8(12). 1060–1071. 37 indexed citations
6.
Klein, Lukas, Florian Wegwitz, Elisa Espinet, et al.. (2022). Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer. JCI Insight. 7(16). 5 indexed citations
7.
Liffers, Sven‐Thorsten, Lena Häberle, Aslihan Yavas, et al.. (2022). Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype. Gut. 72(3). 522–534. 17 indexed citations
8.
Prada, Maria Llamazares, et al.. (2022). Practical Considerations for Complex Tissue Dissociation for Single-Cell Transcriptomics. Methods in molecular biology. 2584. 371–387. 3 indexed citations
9.
Espinet, Elisa, et al.. (2022). Pancreatic Organoids for Regenerative Medicine and Cancer Research. Frontiers in Cell and Developmental Biology. 10. 886153–886153. 19 indexed citations
10.
Houbracken, Isabelle, et al.. (2021). On the Origin of Pancreatic Cancer: Molecular Tumor Subtypes in Perspective of Exocrine Cell Plasticity. Cellular and Molecular Gastroenterology and Hepatology. 13(4). 1243–1253. 28 indexed citations
11.
Berdiel‐Acer, Mireia, Ana Maia, Simone Borgoni, et al.. (2021). Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts. Oncogene. 40(15). 2651–2666. 16 indexed citations
12.
Schaack, D, Andrea S. Bauer, Thomas Giese, et al.. (2021). Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer. Viruses. 13(6). 1019–1019. 4 indexed citations
13.
Bozza, Matthias, Edward W. Green, Elisa Espinet, et al.. (2020). Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models. Molecular Therapy — Methods & Clinical Development. 17. 957–968. 23 indexed citations
14.
Rodríguez‐Vita, Juan, Sven S. Liebler, Carolin Mogler, et al.. (2017). Endothelial Notch1 Activity Facilitates Metastasis. Cancer Cell. 31(3). 355–367. 232 indexed citations
15.
Nadler, Wiebke, Elisa M. Noll, Christian Eisen, et al.. (2016). Identification and Validation of Novel Subtype-Specific Protein Biomarkers in Pancreatic Ductal Adenocarcinoma. Pancreas. 46(3). 311–322. 21 indexed citations
16.
Calon, Alexandre, Enza Lonardo, Antonio Berenguer, et al.. (2015). Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nature Genetics. 47(4). 320–329. 775 indexed citations breakdown →
17.
Calon, Alexandre, Elisa Espinet, Sergio Palomo‐Ponce, et al.. (2012). Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation. Cancer Cell. 22(5). 571–584. 826 indexed citations breakdown →
18.
Coco, Silverio, et al.. (2007). Functional isocyanide metal complexes as building blocks for supramolecular materials: hydrogen-bonded liquid crystals. Dalton Transactions. 3267–3267. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026